Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALUE: Lacosamide Extension for PGTCS in IGE
NCT02408549Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2015
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of lacosamide in idiopathic generalized epilepsy (IGE), sponsored by UCB. Started Aug 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
idiopathic generalized epilepsy (IGE)
Beyond the preview
Go deeper on NCT02408549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408549.